MX369090B - Sultiame para el tratamiento de apnea del sueño. - Google Patents
Sultiame para el tratamiento de apnea del sueño.Info
- Publication number
- MX369090B MX369090B MX2018011607A MX2018011607A MX369090B MX 369090 B MX369090 B MX 369090B MX 2018011607 A MX2018011607 A MX 2018011607A MX 2018011607 A MX2018011607 A MX 2018011607A MX 369090 B MX369090 B MX 369090B
- Authority
- MX
- Mexico
- Prior art keywords
- sultiame
- sleep apnea
- treatment
- drug
- patient
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Se proporciona una terapia nueva para la apnea del sueño que involucra el administrar el fármaco sultiame al paciente.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE1650636 | 2016-05-11 | ||
PCT/EP2017/061081 WO2017194551A1 (en) | 2016-05-11 | 2017-05-09 | Sultiame for the treatment of sleep apnea |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2018011607A MX2018011607A (es) | 2019-01-10 |
MX369090B true MX369090B (es) | 2019-10-29 |
Family
ID=59009652
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2018011607A MX369090B (es) | 2016-05-11 | 2017-05-09 | Sultiame para el tratamiento de apnea del sueño. |
Country Status (16)
Country | Link |
---|---|
US (1) | US10617694B2 (es) |
EP (1) | EP3423062B1 (es) |
JP (1) | JP6514420B2 (es) |
KR (1) | KR101961368B1 (es) |
CN (1) | CN109310699B (es) |
AU (1) | AU2017261680B2 (es) |
BR (1) | BR112018068910A2 (es) |
CA (1) | CA3016110C (es) |
DK (1) | DK3423062T3 (es) |
ES (1) | ES2817582T3 (es) |
IL (1) | IL261984B (es) |
MX (1) | MX369090B (es) |
PL (1) | PL3423062T3 (es) |
PT (1) | PT3423062T (es) |
WO (1) | WO2017194551A1 (es) |
ZA (1) | ZA201806320B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20200281522A1 (en) | 2019-03-06 | 2020-09-10 | Medtronic Xomed, LLC | System and method for improved obstructive sleep apnea diagnostic for implantable devices |
CN114504643B (zh) * | 2021-12-24 | 2024-03-26 | 北京大学第一医院 | 抗IgE抗体在用于治疗OSAS中的应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2916489A (en) | 1955-09-09 | 1959-12-08 | Schenley Ind Inc | Sultames |
SE9504537D0 (sv) | 1995-12-19 | 1995-12-19 | Jan Hedner | Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet |
SE0000601D0 (sv) | 2000-02-24 | 2000-02-24 | Jan Hedner | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet |
SE0400378D0 (sv) | 2004-02-17 | 2004-02-17 | Jan Hedner | Sätt att behandla och diagnostisera andningsstörningar i sömnen och medel för att utföra sättet |
CN101291663A (zh) | 2005-09-16 | 2008-10-22 | 赛诺科学股份公司 | 预防和治疗睡眠呼吸障碍的方法和工具 |
EP1973551A1 (en) | 2005-12-20 | 2008-10-01 | Cereuscience AB | Method and composition for treating and diagnosing restless legs syndrome |
US8071557B2 (en) * | 2007-06-13 | 2011-12-06 | Vivus, Inc. | Treatment of pulmonary hypertension with carbonic anhydrase inhibitors |
US20110053914A1 (en) * | 2009-08-28 | 2011-03-03 | Gruenenthal Gmbh | Pharmaceutical Combination Comprising 6-Dimethylaminomethyl-1-(3-methoxy-phenyl)-cyclohexane-1,3-diol or 6-Dimethylaminomethyl-1-(3-hydroxy-phenyl)-cyclohexane-1,3-diol and an Antiepileptic |
WO2011085256A2 (en) | 2010-01-07 | 2011-07-14 | Vivus, Inc. | Treatment of obstructive sleep apnea syndrome with a combination of a carbonic anhydrase inhibitor and an additional active agent |
WO2016025671A2 (en) | 2014-08-14 | 2016-02-18 | Vivus, Inc. | Treatment of sleep apnea with a combination of a carbonic anhydrase inhibitor and an aldosterone antagonist |
-
2017
- 2017-05-09 PT PT177278058T patent/PT3423062T/pt unknown
- 2017-05-09 MX MX2018011607A patent/MX369090B/es active IP Right Grant
- 2017-05-09 BR BR112018068910A patent/BR112018068910A2/pt not_active Application Discontinuation
- 2017-05-09 CN CN201780027058.7A patent/CN109310699B/zh active Active
- 2017-05-09 CA CA3016110A patent/CA3016110C/en active Active
- 2017-05-09 US US16/300,651 patent/US10617694B2/en active Active
- 2017-05-09 PL PL17727805T patent/PL3423062T3/pl unknown
- 2017-05-09 AU AU2017261680A patent/AU2017261680B2/en active Active
- 2017-05-09 JP JP2018554369A patent/JP6514420B2/ja active Active
- 2017-05-09 EP EP17727805.8A patent/EP3423062B1/en active Active
- 2017-05-09 WO PCT/EP2017/061081 patent/WO2017194551A1/en active Application Filing
- 2017-05-09 KR KR1020187028326A patent/KR101961368B1/ko active IP Right Grant
- 2017-05-09 DK DK17727805.8T patent/DK3423062T3/da active
- 2017-05-09 ES ES17727805T patent/ES2817582T3/es active Active
-
2018
- 2018-09-20 ZA ZA2018/06320A patent/ZA201806320B/en unknown
- 2018-09-27 IL IL261984A patent/IL261984B/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
IL261984B (en) | 2019-07-31 |
CN109310699B (zh) | 2020-02-14 |
ES2817582T3 (es) | 2021-04-07 |
EP3423062B1 (en) | 2020-06-24 |
JP6514420B2 (ja) | 2019-05-15 |
PL3423062T3 (pl) | 2020-12-28 |
JP2019511555A (ja) | 2019-04-25 |
ZA201806320B (en) | 2019-08-28 |
DK3423062T3 (da) | 2020-08-31 |
BR112018068910A2 (pt) | 2019-01-22 |
KR101961368B1 (ko) | 2019-03-25 |
US20190201411A1 (en) | 2019-07-04 |
WO2017194551A1 (en) | 2017-11-16 |
EP3423062A1 (en) | 2019-01-09 |
MX2018011607A (es) | 2019-01-10 |
KR20180113626A (ko) | 2018-10-16 |
PT3423062T (pt) | 2020-08-31 |
IL261984A (en) | 2018-10-31 |
AU2017261680B2 (en) | 2019-06-27 |
CN109310699A (zh) | 2019-02-05 |
AU2017261680A1 (en) | 2018-10-04 |
US10617694B2 (en) | 2020-04-14 |
CA3016110C (en) | 2020-09-01 |
CA3016110A1 (en) | 2017-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2020004023A (es) | Uso de un inhibidor de pcsk9 para tratar la hiperlipidemia. | |
MX2016010504A (es) | Metodos para el tratamiento de pacientes con hipercolesterolemia que no esta controlada adecuadamente por una terapia con estatinas de dosis moderada referencia cruzada a solicitudes relacionas. | |
PH12016502354A1 (en) | Pharmaceutical composition | |
MX2021000289A (es) | Inhibidores pcsk9 para usarse en el tratamiento de hipercolesterolemia. | |
MY174727A (en) | Stable, protracted glp-1/glucagon receptor co-agonists for medical use | |
EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
MY188139A (en) | Sodium channel modulators for the treatment of pain | |
EP3141603A4 (en) | Gpc3-targeted therapeutic agent for administration to patients for whom gpc3-targeted therapeutic agent therapy is effective | |
MX2017015896A (es) | Agente anticancerigeno. | |
PH12016502352A1 (en) | Pharmaceutical composition | |
MX2017006938A (es) | Terapia de combinacion para el tratamiento de cancer. | |
MX2016009231A (es) | Administracion de tasimelteon en condiciones de ayuno. | |
MX2018002223A (es) | Derivados de insulina novedosos y usos medicos de los mismos. | |
MX2015012315A (es) | Uso de levocetirizina y montelukast en el tratamiento de lesion traumatica. | |
PH12017500392A1 (en) | Medical treatments based on anamorelin | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
NZ720273A (en) | Preparations and methods for treating a gd2 positive cancer | |
NZ734750A (en) | Cancer therapy with a parvovirus combined with bevacizumab | |
MX369090B (es) | Sultiame para el tratamiento de apnea del sueño. | |
MX2017005807A (es) | Inmunoterapia especifica de multipeptidos t terapeuticos para el tratamiento de metastasis cerebrales. | |
MY195767A (en) | Treatment of Androgen Deprivation Therapy Associated Symptoms | |
TW201613599A (en) | Use of composition for manufacture of medicament for suppressing androgen receptor related function and treatment of androgen receptor related disease | |
NZ713490A (en) | Oral suspension for treating eosinophilic esophagitis | |
UA115887U (xx) | Спосіб терапії порушень фолікулогенезу у хворих на синдром полікістозних яєчників | |
GB201518063D0 (en) | Chrono-parenteral administration of high-dose melatonin to treat severe disrupted circadian rhythm in critically ill patients |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |